Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification

BackgroundTo date, few reports have investigated genetic alterations and clinicopathological features in cardia and noncardia gastric cancer (GC).MethodsIn total, 435 GC patients receiving curative surgery were included. The clinicopathological features, recurrence patterns, prognoses and genetic al...

Full description

Bibliographic Details
Main Authors: Shih-Min Pai, Kuo-Hung Huang, Ming-Huang Chen, Wen-Liang Fang, Yee Chao, Su-Shun Lo, Anna Fen-Yau Li, Chew-Wun Wu, Yi-Ming Shyr
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.632609/full
id doaj-4ee9d93cf9b54591bf5daa3022ea75c7
record_format Article
spelling doaj-4ee9d93cf9b54591bf5daa3022ea75c72021-06-08T05:14:25ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-06-011110.3389/fonc.2021.632609632609Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren ClassificationShih-Min Pai0Shih-Min Pai1Kuo-Hung Huang2Kuo-Hung Huang3Ming-Huang Chen4Ming-Huang Chen5Wen-Liang Fang6Wen-Liang Fang7Yee Chao8Yee Chao9Su-Shun Lo10Su-Shun Lo11Anna Fen-Yau Li12Anna Fen-Yau Li13Chew-Wun Wu14Chew-Wun Wu15Yi-Ming Shyr16Yi-Ming Shyr17Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanDivision of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanCenter of Immuno-Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, TaiwanDivision of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanCenter of Immuno-Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanDepartment of Surgery, National Yang Ming Chiao Tung University Hospital, Yilan, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanDepartment of Pathology, Taipei Veterans General Hospital, Taipei, TaiwanDivision of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanDivision of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanBackgroundTo date, few reports have investigated genetic alterations and clinicopathological features in cardia and noncardia gastric cancer (GC).MethodsIn total, 435 GC patients receiving curative surgery were included. The clinicopathological features, recurrence patterns, prognoses and genetic alterations were compared between cardia and noncardia GC patients.ResultsAmong the 435 enrolled patients, 47 (10.8%) had cardia GC. Compared with noncardia GC, cardia GC was associated with more intestinal-type tumors and similar initial recurrence patterns and 5-year overall survival (OS; 50.8% vs. 50.5%, P = 0.480) and disease-free survival (DFS; 48.6% vs. 48.9%, P = 0.392) rates. For both intestinal-type GC and diffuse-type GC, the clinicopathological features and 5-year OS and DFS rates were not significantly different between the cardia and noncardia GC patients. Multivariable analysis showed that cardia GC was not an independent prognostic factor. Compared with noncardia GC, cardia GC was associated with increased PIK3CA amplification than in patients with intestinal-type GC and was associated with increased HER2 expression in patients with diffuse-type GC.ConclusionsCardia GC is not an independent prognostic factor. In cardia GC patients with intestinal-type GC, PIK3CA amplification was more common, and in those with diffuse-type GC, HER2 expression was more common. Targeted therapy may be beneficial for these patient subgroups.https://www.frontiersin.org/articles/10.3389/fonc.2021.632609/fullgastric cancercardianoncardiagenetic alterationPIK3CA amplificationHER2 expression
collection DOAJ
language English
format Article
sources DOAJ
author Shih-Min Pai
Shih-Min Pai
Kuo-Hung Huang
Kuo-Hung Huang
Ming-Huang Chen
Ming-Huang Chen
Wen-Liang Fang
Wen-Liang Fang
Yee Chao
Yee Chao
Su-Shun Lo
Su-Shun Lo
Anna Fen-Yau Li
Anna Fen-Yau Li
Chew-Wun Wu
Chew-Wun Wu
Yi-Ming Shyr
Yi-Ming Shyr
spellingShingle Shih-Min Pai
Shih-Min Pai
Kuo-Hung Huang
Kuo-Hung Huang
Ming-Huang Chen
Ming-Huang Chen
Wen-Liang Fang
Wen-Liang Fang
Yee Chao
Yee Chao
Su-Shun Lo
Su-Shun Lo
Anna Fen-Yau Li
Anna Fen-Yau Li
Chew-Wun Wu
Chew-Wun Wu
Yi-Ming Shyr
Yi-Ming Shyr
Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification
Frontiers in Oncology
gastric cancer
cardia
noncardia
genetic alteration
PIK3CA amplification
HER2 expression
author_facet Shih-Min Pai
Shih-Min Pai
Kuo-Hung Huang
Kuo-Hung Huang
Ming-Huang Chen
Ming-Huang Chen
Wen-Liang Fang
Wen-Liang Fang
Yee Chao
Yee Chao
Su-Shun Lo
Su-Shun Lo
Anna Fen-Yau Li
Anna Fen-Yau Li
Chew-Wun Wu
Chew-Wun Wu
Yi-Ming Shyr
Yi-Ming Shyr
author_sort Shih-Min Pai
title Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification
title_short Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification
title_full Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification
title_fullStr Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification
title_full_unstemmed Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification
title_sort cardia gastric cancer is associated with increased pik3ca amplifications and her2 expression than noncardia gastric cancer according to lauren classification
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-06-01
description BackgroundTo date, few reports have investigated genetic alterations and clinicopathological features in cardia and noncardia gastric cancer (GC).MethodsIn total, 435 GC patients receiving curative surgery were included. The clinicopathological features, recurrence patterns, prognoses and genetic alterations were compared between cardia and noncardia GC patients.ResultsAmong the 435 enrolled patients, 47 (10.8%) had cardia GC. Compared with noncardia GC, cardia GC was associated with more intestinal-type tumors and similar initial recurrence patterns and 5-year overall survival (OS; 50.8% vs. 50.5%, P = 0.480) and disease-free survival (DFS; 48.6% vs. 48.9%, P = 0.392) rates. For both intestinal-type GC and diffuse-type GC, the clinicopathological features and 5-year OS and DFS rates were not significantly different between the cardia and noncardia GC patients. Multivariable analysis showed that cardia GC was not an independent prognostic factor. Compared with noncardia GC, cardia GC was associated with increased PIK3CA amplification than in patients with intestinal-type GC and was associated with increased HER2 expression in patients with diffuse-type GC.ConclusionsCardia GC is not an independent prognostic factor. In cardia GC patients with intestinal-type GC, PIK3CA amplification was more common, and in those with diffuse-type GC, HER2 expression was more common. Targeted therapy may be beneficial for these patient subgroups.
topic gastric cancer
cardia
noncardia
genetic alteration
PIK3CA amplification
HER2 expression
url https://www.frontiersin.org/articles/10.3389/fonc.2021.632609/full
work_keys_str_mv AT shihminpai cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT shihminpai cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT kuohunghuang cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT kuohunghuang cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT minghuangchen cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT minghuangchen cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT wenliangfang cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT wenliangfang cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT yeechao cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT yeechao cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT sushunlo cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT sushunlo cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT annafenyauli cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT annafenyauli cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT chewwunwu cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT chewwunwu cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT yimingshyr cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
AT yimingshyr cardiagastriccancerisassociatedwithincreasedpik3caamplificationsandher2expressionthannoncardiagastriccanceraccordingtolaurenclassification
_version_ 1721390037194506240